Search research articles
Contact Us
Filters
Showing results (171-180 of 269) with videos related to
Page
of 27
Sort By:
Biological Psychiatry
|
February 15, 1992
Effect of fenfluramine on mood: a double-blind placebo-controlled trial
P Lichtenberg, B Shapira, M Blacker, et al.
Comprehensive Psychiatry
|
March 5, 2004
Illness recognition and disruptiveness in psychotic illness
K Kanyas, O Karni, A Hamdan, et al.
Journal of Psychiatric Research
|
January 1, 1991
Post-traumatic stress disorder: issues of co-morbidity
Z Solomon, A Bleich, M Koslowsky, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1995
Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse
U Heresco-Levy, D Greenberg, B Lerer, et al.
European Journal of Radiology
|
February 1, 1996
Brain SPECT imaging of neuropsychiatric disorders
Y Krausz, O Bonne, R Marciano, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1987
A study of the discriminating power of the Wechsler Memory Scale using schizophrenic and normal subjects in Israel
S Chazan, A Calev, T Gil, et al.
The International Journal of Neuropsychopharmacology
|
October 17, 2019
Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree - CORRIGENDUM
O Teltsh, K Kanyas-Sarner, A Rigbi, et al.
Biological Psychiatry
|
February 1, 1995
Absence of reduced platelet adenylate cyclase activity in Vietnam veterans with PTSD
Y Kohn, M E Newman, B Lerer, et al.
The Pharmacogenomics Journal
|
August 30, 2007
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia
R C Smith, R H Segman, T Golcer-Dubner, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1997
Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy
U Heresco-Levy, D Greenberg, B Lerer, et al.
Page
of 27
Search research articles
Search
Showing results (171-180 of 269) with videos related to
Sort By:
Page
of 27
Biological Psychiatry
|
February 15, 1992
Effect of fenfluramine on mood: a double-blind placebo-controlled trial
P Lichtenberg, B Shapira, M Blacker, et al.
Comprehensive Psychiatry
|
March 5, 2004
Illness recognition and disruptiveness in psychotic illness
K Kanyas, O Karni, A Hamdan, et al.
Journal of Psychiatric Research
|
January 1, 1991
Post-traumatic stress disorder: issues of co-morbidity
Z Solomon, A Bleich, M Koslowsky, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1995
Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse
U Heresco-Levy, D Greenberg, B Lerer, et al.
European Journal of Radiology
|
February 1, 1996
Brain SPECT imaging of neuropsychiatric disorders
Y Krausz, O Bonne, R Marciano, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1987
A study of the discriminating power of the Wechsler Memory Scale using schizophrenic and normal subjects in Israel
S Chazan, A Calev, T Gil, et al.
The International Journal of Neuropsychopharmacology
|
October 17, 2019
Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree - CORRIGENDUM
O Teltsh, K Kanyas-Sarner, A Rigbi, et al.
Biological Psychiatry
|
February 1, 1995
Absence of reduced platelet adenylate cyclase activity in Vietnam veterans with PTSD
Y Kohn, M E Newman, B Lerer, et al.
The Pharmacogenomics Journal
|
August 30, 2007
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia
R C Smith, R H Segman, T Golcer-Dubner, et al.
The Israel Journal of Psychiatry and Related Sciences
|
January 1, 1997
Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy
U Heresco-Levy, D Greenberg, B Lerer, et al.
Page
of 27